Glycine → Phenylalanine Serine

HRID 4417

Reaktionsgleichung

[NH2:1][C@H:2]([C:10]([OH:12])=[O:11])[CH2:3][C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=1.[NH2:13][CH2:14][C:15]([OH:17])=[O:16]>>[NH2:1][C@H:2]([C:10]([OH:12])=[O:11])[CH2:3][C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=1.[NH2:13][C@H:14]([C:15]([OH:17])=[O:16])[CH2:10][OH:11]

Komponenten

Edukt 2

HCID 750Glycine

HCID 6140L-Phenylalanine

Produkt 1

HCID 18611619Phenylalanine Serine

Versuchsvorschrift

The formation of t-Boc--Phe--SerOH is obtained by the same process, but using 1.1 mmol of lyophilised hydrated serine in place of cysteine and 1 mmol of phenylalanine protected by t-Box and activated in place of glycine.

Aufarbeitung

customThe formation of t-Boc--Phe--SerOH is obtained by the same process

Quellen und Nachweise

ORD-Eintrag: ord-bf52adeae66d476a983fab8d71fb9ecb
Quelldatensatz: uspto-grants-1988_02
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US04725645

Verknüpfte Notizen

Wird geladen…